176 related articles for article (PubMed ID: 37307213)
1. Retrospective characterization of nodal marginal zone lymphoma.
Stuver R; Drill E; Qualls D; Okwali M; Lee Batlevi C; Caron PC; Dogan A; Epstein-Peterson ZD; Falchi L; Hamlin PA; Horwitz SM; Imber BS; Intlekofer AM; Johnson WT; Khan N; Kumar A; Lahoud OB; Lue JK; Matasar MJ; Moskowitz AJ; Noy A; Owens CN; Palomba ML; Schöder H; Vardhana SA; Yahalom J; Zelenetz AD; Salles G; Straus DJ
Blood Adv; 2023 Sep; 7(17):4838-4847. PubMed ID: 37307213
[TBL] [Abstract][Full Text] [Related]
2. Nodal marginal zone B-cell lymphoma: Analysis of 36 cases. Clinical presentation and treatment outcomes of nodal marginal zone B-cell lymphoma.
Oh SY; Ryoo BY; Kim WS; Kim K; Lee J; Kim HJ; Kwon JM; Lee HR; Ko YH; Oh SJ; Park KW; Kim HJ; Kwon HC; Nam E; Kim JH; Park YH; Lee SS; Kim HY; Park K
Ann Hematol; 2006 Nov; 85(11):781-6. PubMed ID: 16847665
[TBL] [Abstract][Full Text] [Related]
3. Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab era.
Starr AG; Caimi PF; Fu P; Massoud MR; Meyerson H; Hsi ED; Mansur DB; Cherian S; Cooper BW; De Lima MJ; Lazarus HM; Gerson SL; Jagadeesh D; Smith MR; Dean RM; Pohlman BL; Hill BT; William BM
Br J Haematol; 2016 Oct; 175(2):275-280. PubMed ID: 27443247
[TBL] [Abstract][Full Text] [Related]
4. Pediatric nodal marginal zone lymphoma may develop in the adult population.
Gitelson E; Al-Saleem T; Robu V; Millenson MM; Smith MR
Leuk Lymphoma; 2010 Jan; 51(1):89-94. PubMed ID: 19863176
[TBL] [Abstract][Full Text] [Related]
5. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
6. Clinical Characteristics, Treatment and Evolution of Splenic and Nodal Marginal Zone Lymphomas-Retrospective and Multicentric Analysis of Portuguese Centers.
Rodrigues CD; Peixeiro RP; Viegas D; Chorão P; Couto ME; Gaspar CL; Fernandes JP; Alves D; Ribeiro LA; de Vasconcelos M P; Tomé AL; Badior M; Coelho H; Príncipe F; Chacim S; da Silva MG; Coutinho R
Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):e839-e844. PubMed ID: 34326035
[TBL] [Abstract][Full Text] [Related]
7. Nodal marginal zone lymphoma: Clinical features, diagnosis, management and treatment.
Tadmor T; Polliack A
Best Pract Res Clin Haematol; 2017; 30(1-2):92-98. PubMed ID: 28288722
[TBL] [Abstract][Full Text] [Related]
8. High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO.
Avivi I; Arcaini L; Ferretti VV; Boumendil A; Finel H; Milone G; Zaja F; Liliana D; Musso M; Didier B; Bachy E; Wattad M; Nicolas-Virelizier E; Gramatzki M; Bourhis JH; Caillot D; Haenel A; Held G; Thieblemont C; Jindra P; Pohlreich D; Guilhot F; Kroschinsky F; Wahlin B; Scheid C; Ifrah N; Berthou C; Dreger P; Montoto S; Conconi A
Br J Haematol; 2018 Sep; 182(6):807-815. PubMed ID: 29984825
[TBL] [Abstract][Full Text] [Related]
9. [Transformation of CD5-positive nodal marginal zone lymphoma to diffuse large B-cell lymphoma].
Koike T; Iriyama N; Nakagawa M; Takahashi H; Hamada T; Uchino Y; Miura K; Hatta Y; Nakayama T; Takei M
Rinsho Ketsueki; 2020; 61(3):245-250. PubMed ID: 32224585
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of patients with nodal marginal zone lymphoma compared to follicular lymphoma: similar presentation, but differences in prognostic factors and rate of transformation.
van den Brand M; van der Velden WJ; Diets IJ; Ector GI; de Haan AF; Stevens WB; Hebeda KM; Groenen PJ; van Krieken HJ
Leuk Lymphoma; 2016 Jul; 57(7):1649-56. PubMed ID: 26694256
[TBL] [Abstract][Full Text] [Related]
11. Canine nodal marginal zone lymphoma: Descriptive insight into the biological behaviour.
Cozzi M; Marconato L; Martini V; Aresu L; Riondato F; Rossi F; Stefanello D; Comazzi S
Vet Comp Oncol; 2018 Jun; 16(2):246-252. PubMed ID: 29205839
[TBL] [Abstract][Full Text] [Related]
12. The bendamustine plus rituximab regimen is active against primary nodal marginal zone B-cell lymphoma.
Laribi K; Tempescul A; Ghnaya H; Denizon N; Besançon A; Anghel A; Farhi J; Truong C; Lemaire P; Poulain S; Bolle D; Ianotto JC; Baugier de Materre A
Hematol Oncol; 2017 Dec; 35(4):536-541. PubMed ID: 27443419
[TBL] [Abstract][Full Text] [Related]
13. Disparate survival outcomes after front-line chemoimmunotherapy in older patients with follicular, nodal marginal zone and small lymphocytic lymphoma.
Olszewski AJ; Shafqat H; Ali S
Leuk Lymphoma; 2015 Apr; 56(4):942-50. PubMed ID: 24956144
[TBL] [Abstract][Full Text] [Related]
14. Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients.
Morigi A; Argnani L; Lolli G; Broccoli A; Pellegrini C; Nanni L; Stefoni V; Coppola PE; Carella M; Casadei B; Sabattini E; Cavo M; Zinzani PL
Hematol Oncol; 2020 Oct; 38(4):487-492. PubMed ID: 32594531
[TBL] [Abstract][Full Text] [Related]
15. Results of Upfront Therapy for Marginal Zone Lymphoma.
Ortega JL; Cabanillas F; Rivera N; Tirado-Gomez M; Hallman D; Pardo WI; Bruno M
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):879-883. PubMed ID: 29042174
[TBL] [Abstract][Full Text] [Related]
16. Nodal marginal zone lymphoma.
Angelopoulou MK; Kalpadakis C; Pangalis GA; Kyrtsonis MC; Vassilakopoulos TP
Leuk Lymphoma; 2014 Jun; 55(6):1240-50. PubMed ID: 24004184
[TBL] [Abstract][Full Text] [Related]
17. Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination.
Arcaini L; Burcheri S; Rossi A; Passamonti F; Paulli M; Boveri E; Brusamolino E; Orlandi E; Molteni A; Pulsoni A; Cox MC; Orsucci L; Fabbri A; Frezzato M; Voso MT; Zaja F; Montanari F; Pascutto C; Morra E; Cortelazzo S; Lazzarino M
Oncologist; 2006 Mar; 11(3):285-91. PubMed ID: 16549813
[TBL] [Abstract][Full Text] [Related]
18. Contemporary management of nodal and primary splenic marginal zone lymphoma.
Leslie LA; Feldman TA; McNeill A; Timberg M; Iida H; Goy AH
Expert Rev Hematol; 2019 Dec; 12(12):1011-1022. PubMed ID: 31619091
[No Abstract] [Full Text] [Related]
19. Children and adolescents with marginal zone lymphoma have an excellent prognosis with limited chemotherapy or a watch-and-wait strategy after complete resection.
Ronceray L; Abla O; Barzilai-Birenboim S; Bomken S; Chiang AK; Jazbec J; Kabickova E; Lazic J; Beishuizen A; Mellgren K; Tanaka F; Pillon M; Devalck C; Gouttenoire M; Makarova O; Burkhardt B; Attarbaschi A;
Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286565
[TBL] [Abstract][Full Text] [Related]
20. [Nodal marginal zone B-cell lymphoma: a clinicopathologic study of 10 cases].
Zhang YN; Zhou XG; Zhang SH; Zheng YY; Liu WH
Zhonghua Bing Li Xue Za Zhi; 2007 Aug; 36(8):529-33. PubMed ID: 17980100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
